#painmanagement #healthcare #pain #TrisPharma #ALLEVIATE1clinicaltrial #cebranopadol #Phase3trial #painrelief #acutepain #abdominoplasty #primaryendpoint #reducingpainintensity #Painintensity #NRSscale #analgesia #opioids #painmanagement #NDAsubmission
pharmatimes.com/news/tris-ph...
pharmatimes.com/news/tris-ph...
Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol - PharmaTimes
Phase 3 trial shows promising pain relief for acute pain patients
pharmatimes.com
January 28, 2025 at 12:30 PM